Medicare Enrolled
Dr. Amanda Hathaway, M.D.
Hematology & Oncology · Athens, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hathaway from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hathaway?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hathaway
Dr. Amanda Hathaway is a hematology & oncology specialist in Athens, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Hathaway performed 20,581 Medicare services across 2,545 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hathaway received a total of $140,609 from 76 pharmaceutical and/or device companies across 847 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hathaway is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 15% volume in GA
$140,609 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,581
Medicare services
Top 15% in GA for hematology & oncology
2,545
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,372 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,690 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 2,400 | $18 | $74 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
2,340 | $36 | $153 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,212 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
620 | $6 | $42 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
465 | $92 | $418 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
433 | $8 | $38 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
420 | $8 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 328 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
214 | $20 | $237 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
209 | $10 | $66 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
209 | $6 | $30 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
209 | $4 | $22 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
160 | $10 | $78 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
140 | $90 | $589 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
87 | $130 | $495 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
83 | $65 | $283 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
74 | $1 | $5 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
73 | $2 | $9 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
62 | $1 | $7 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 58 | $310 | $2,115 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
55 | $59 | $253 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
53 | $13 | $48 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
52 | $76 | $745 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
52 | $20 | $115 |
| Iron level test | 51 | $6 | $28 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
51 | $9 | $38 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
49 | $44 | $254 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
48 | $158 | $1,123 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
47 | $43 | $289 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
45 | $9 | $40 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
45 | $11 | $68 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
42 | $15 | $74 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
42 | $14 | $73 |
| New patient office visit, complex (60-74 min) | 39 | $160 | $709 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $111 | $562 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
33 | $1 | $2 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
32 | $14 | $64 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
30 | $13 | $48 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
30 | $22 | $152 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
30 | $92 | $386 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
29 | $8 | $48 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
28 | $4 | $17 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $94 | $476 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
21 | $13 | $48 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
20 | $26 | $151 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
20 | $50 | $298 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
17 | $7 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $121 | $706 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
16 | $24 | $108 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
15 | $16 | $73 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
13 | $59 | $598 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
13 | $73 | $668 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.3% high complexity
36.3% medium
13.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$140,609
Total received (2018-2024)
Avg $20,087/year across 7 years
Top 4% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
847
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$110,461 (78.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,696 (10.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,183 (10.1%)
Other
Charitable contributions, space rental, and other categories
$1,268 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$22,609
2023
$24,628
2022
$28,072
2021
$20,513
2020
$27,619
2019
$10,994
2018
$6,174
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$15,877
AstraZeneca Pharmaceuticals LP
$2,783
Novartis Pharmaceuticals Corporation
$1,169
BeiGene USA, Inc.
$711
Janssen Biotech, Inc.
$191
Daiichi Sankyo Inc.
$159
Merck Sharp & Dohme LLC
$156
ABBVIE INC.
$148
PFIZER INC.
$135
Gilead Sciences, Inc.
$128
Bayer Healthcare Pharmaceuticals Inc.
$122
GlaxoSmithKline, LLC.
$115
SOBI, INC
$102
Celgene Corporation
$90
Takeda Pharmaceuticals U.S.A., Inc.
$76
Alexion Pharmaceuticals, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$57
Genmab U.S., Inc.
$54
Kyowa Kirin, Inc.
$48
Stemline Therapeutics Inc.
$45
Sumitomo Pharma America, Inc.
$42
Rigel Pharmaceuticals, Inc.
$35
Dendreon Pharmaceuticals LLC
$29
SERVIER PHARMACEUTICALS LLC
$25
E.R. Squibb & Sons, L.L.C.
$21
JAZZ PHARMACEUTICALS INC.
$21
Astellas Pharma US Inc
$20
RECORDATI_RARE_DISEASES_INC.
$20
Ipsen Biopharmaceuticals, Inc
$18
EMD Serono, Inc.
$18
Exelixis Inc.
$18
Eisai Inc.
$17
Amgen Inc.
$16
Genentech USA, Inc.
$16
Mirati Therapeutics, Inc.
$15
Incyte Corporation
$15
Spectrum Pharmaceuticals Inc.
$14
ARRAY BIOPHARMA INC
$13
Top 3 companies account for 87.7% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$93,227
Alexion Pharmaceuticals, Inc.
$15,630
Novartis Pharmaceuticals Corporation
$8,614
PFIZER INC.
$3,906
AstraZeneca Pharmaceuticals LP
$3,403
Immunomedics, Inc.
$2,200
Gilead Sciences, Inc.
$1,848
Pharmacosmos Therapeutics Inc.
$1,500
Daiichi Sankyo Inc.
$1,432
BeiGene USA, Inc.
$711
Genentech USA, Inc.
$673
Janssen Biotech, Inc.
$544
Eli Lilly and Company
$517
E.R. Squibb & Sons, L.L.C.
$512
Amgen Inc.
$388
ABBVIE INC.
$337
Astellas Pharma US Inc
$295
Celgene Corporation
$280
GlaxoSmithKline, LLC.
$273
Merck Sharp & Dohme LLC
$269
Merck Sharp & Dohme Corporation
$267
Pharmacyclics LLC, An AbbVie Company
$239
GENZYME CORPORATION
$225
Regeneron Healthcare Solutions, Inc.
$207
Bayer Healthcare Pharmaceuticals Inc.
$195
Eisai Inc.
$191
Puma Biotechnology, Inc.
$179
Takeda Pharmaceuticals U.S.A., Inc.
$149
Incyte Corporation
$127
Jazz Pharmaceuticals Inc.
$125
Kyowa Kirin, Inc.
$115
Stemline Therapeutics Inc.
$111
Bayer HealthCare Pharmaceuticals Inc.
$106
SOBI, INC
$102
NOVARTIS PHARMACEUTICALS CORPORATION
$100
Agios Pharmaceuticals, Inc.
$97
Seagen Inc.
$93
Rigel Pharmaceuticals, Inc.
$83
Exelixis Inc.
$81
AMAG Pharmaceuticals, Inc.
$79
Taiho Oncology, Inc.
$76
EISAI INC.
$70
Ipsen Biopharmaceuticals, Inc
$69
TerSera Therapeutics LLC
$62
Sirtex Medical Inc
$59
JAZZ PHARMACEUTICALS INC.
$55
Genmab U.S., Inc.
$54
Dendreon Pharmaceuticals LLC
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
GE HEALTHCARE
$45
Sumitomo Pharma America, Inc.
$42
G1 Therapeutics, Inc.
$40
Adaptive Biotechnologies Corporation
$37
Clovis Oncology, Inc.
$36
Teva Pharmaceuticals USA, Inc.
$34
EMD Serono, Inc.
$32
Helsinn Therapeutics (U.S.), Inc.
$30
ARRAY BIOPHARMA INC
$25
SERVIER PHARMACEUTICALS LLC
$25
PUMA BIOTECHNOLOGY, INC.
$25
Blueprint Medicines Corporation
$24
TAIHO ONCOLOGY, INC.
$24
RECORDATI_RARE_DISEASES_INC.
$20
CTI BioPharma Corp.
$18
Deciphera Pharmaceuticals Inc.
$18
AbbVie Inc.
$17
Fortovia Therapeutics, Inc.
$16
Dova Pharmaceuticals
$15
Kite Pharma, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$15
Mirati Therapeutics, Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
MorphoSys, US Inc.
$13
Pharmacyclics LLC, an AbbVie Company
$13
Verastem, Inc.
$12
Secura Bio, Inc.
$11
Top 3 companies account for 83.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Avastin · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DIFICID · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FASLODEX · FERAHEME · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · Monoferric · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · Stivarga · TAFINLAR · TAGRISSO · TALVEY · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TRODELVY · TUKYSA · Tavalisse · Tibsovo · Trodelvy · Truqap · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vitrakvi · Vonjo · Vyloy · XALKORI · XOSPATA · XTANDI · Xermelo · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for hematology & oncology in GA.
Geographic Context
Hematology & oncology specialists within 10 mi
10
Per 100K population
12.4
County median income
$85,012
Nearest hospital
ST MARY'S HOSPITAL
5.4 mi
5.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hathaway is a mixed practice specialist, with above-average Medicare volume (top 15% in GA), with speaking/promotional industry engagement in the top 4% of GA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hathaway experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hathaway performed 9,690 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hathaway receive payments from pharmaceutical companies?
Yes. Dr. Hathaway received a total of $140,609 from 76 companies across 847 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hathaway's costs compare to other hematology & oncology specialists in Athens?
Dr. Hathaway's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hathaway) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Athens
Browse hematology & oncology specialists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology